Catalyst Pharmaceuticals, Inc. CPRX · Stock Open Catalyst Pharmaceuticals, Inc. in new tab
Catalyst Pharmaceuticals, Inc. Analysis (CPRX)
Is Catalyst Pharmaceuticals, Inc. a good investment? Catalyst Pharmaceuticals, Inc. (CPRX) is currently trading at 31.49 USD. Market analysts have a consensus price target of 31.67 USD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 18.20. This valuation is generally in line with the broader market.
Earnings Schedule: Catalyst Pharmaceuticals, Inc. is expected to release its next earnings report on Aug. 5, 2026. The market consensus estimate for Forward EPS is 3.48.
Investor FAQ
Does Catalyst Pharmaceuticals, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Aug. 5, 2026. The company currently has a trailing EPS of 1.73.
Company Profile
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizure; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy. The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Community Discussion